证券时报e公司讯,莎普爱思(603168)1月7日晚间公告,近日,公司收到国家药品监督管理局核准签发的头孢克肟颗粒《药品补充申请批准通知书》。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.